Latent EBV genomes undergo epigenetic modifications that determine the host cell-dependent activity of EBV latency promoters and may prevent productive viral replication. The epigenotype of cells in ...

Scientists at The Wistar Institute and colleagues say they have identified a new potential pathway for developing therapeutics that target Epstein-Barr virus (EBV). They discovered that the way the ...

Francesca has an MSci in Biochemistry from the University of Birmingham.View full profile Francesca has an MSci in Biochemistry from the University of Birmingham. Epstein-Barr Virus (EBV) is very ...

Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute, part of the National Institutes of Health, to investigate the molecular mechanisms by which ...

Researchers at the Wistar Institute and their collaborators say they have discovered a potential target for gastric cancers associated with Epstein-Barr Virus. The study “Decitabine disrupts EBV ...

In a recent study posted to the medRxiv* preprint server, researchers at the University of California, San Francisco, and Monogram Biosciences examined the connections between the post-acute sequelae ...